Cogent Biosciences, Inc. (COGT) Operating income 2017–2025
Cogent Biosciences, Inc. (COGT) annual operating income history from SEC filings — each fiscal year as reported.
-$333.4MFY2025 · since FY2017: -$26.2M → -$333.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$333.4M | -20.8% |
| FY2024 | -$275.9M | -32.6% |
| FY2023 | -$208.1M | -40.8% |
| FY2022 | -$147.8M | -95.7% |
| FY2021 | -$75.6M | +8.1% |
| FY2020 | -$82.2M | -155.5% |
| FY2019 | -$32.2M | +10.6% |
| FY2018 | -$36.0M | -37.7% |
| FY2017 | -$26.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice